Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

2.03
+0.01000.50%
Post-market: 2.030.00000.00%16:10 EST
Volume:154.33K
Turnover:311.59K
Market Cap:256.40M
PE:-4.08
High:2.08
Open:2.03
Low:1.97
Close:2.02
52wk High:2.54
52wk Low:0.6200
Shares:126.31M
Float Shares:46.28M
Volume Ratio:0.94
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4981
EPS(LYR):-0.5643
ROE:-32.00%
ROA:-19.37%
PB:1.52
PE(LYR):-3.60

Loading ...

Nautilus Biotechnology Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Feb 05

Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease

GlobeNewswire
·
Jan 28

Nautilus Unveils Single-Molecule Proteomics Platform for Mapping Tau Proteoforms in Alzheimer's Research

Reuters
·
Jan 08

3 Penny Stocks With Market Caps Under $700M

Simply Wall St.
·
Jan 08

Penny Stocks To Consider In December 2025

Simply Wall St.
·
Dec 02, 2025

Nautilus Biotechnology Chief Marketing Officer Kentaro Suzuki Acquires Common Shares

Reuters
·
Nov 11, 2025

Nautilus Biotechnology Regains Nasdaq Compliance After Transfer to Capital Market

Reuters
·
Nov 04, 2025

Nautilus Biotechnology Unveils Reproducible Single-Molecule Proteomics Data at Buck Institute

Reuters
·
Nov 03, 2025

Nautilus Biotechnology Faces Nasdaq Delisting Risk Amid Compliance Challenges

TIPRANKS
·
Oct 30, 2025

Nautilus Q3 2025 Earnings Call Summary and Q&A Highlights: Tau Assay Progress and Strategic Collaborations

Earnings Call
·
Oct 29, 2025

Nautilus (NAUT) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Oct 29, 2025

Nautilus Biotechnolgy (NAUT) Gets a Buy from TD Cowen

TIPRANKS
·
Oct 29, 2025

BRIEF-Nautilus Biotechnology Q3 EPS USD -0.11

Reuters
·
Oct 28, 2025

Nautilus Biotechnology Inc - Early Access Program With Tau Proteoforms Expected in H1 2026

THOMSON REUTERS
·
Oct 28, 2025

Nautilus Biotechnology Q3 Net Income USD -13.574 Million

THOMSON REUTERS
·
Oct 28, 2025

Nautilus Biotechnology Q3 Operating Expenses USD 15.472 Million

THOMSON REUTERS
·
Oct 28, 2025

Press Release: Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

Dow Jones
·
Oct 28, 2025

BRIEF-Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing

Reuters
·
Oct 28, 2025

Nautilus Biotechnology Q3 EPS $(0.11) Beats $(0.15) Estimate. Cash And Equivalents Of $168.5M

Benzinga
·
Oct 28, 2025

Nautilus Biotechnology Inc - Expect to Launch Early Access Program With Tau Proteoforms in the First Half of 2026

THOMSON REUTERS
·
Oct 28, 2025